The “gaditana” biotechnology company Bionaturis (ticker BNT) will host next September 11th the Biotech CTA committee titled “Second generation vaccines: human and animal health applications”.

The event will bring together worldwide references in the field, from both scientific and industrial sides, along with the committee members. There will be an unique opportunity to discuss about the last breakthroughs, trends and new challenges of the new generation vaccines and its key role in the present and future of the world health.

The event is only for CTA members (